Cognitive Longevity
Making brain health screening as routine and accessible as any other essential health check
We combine patented intracellular multi-omics analytics using DNA nanoprobes, Proteomics, and AI to uncover novel pathways for Neurodegenerative diseases
We combine patented intracellular analytics using DNA nanoprobes with AI to diagnose neurodegenerative diseases before symptoms manifest.
We use patented DNA nanotechnology
A paradigm shift in understanding how Alzheimer’s and Parkinson’s diseases manifests opens up a whole new way of diagnosing, treating and managing the disease.
We Use Patented DNA Nanotechnology
A paradigm shift in understanding how Alzheimer’s disease manifests opens up a whole new way of diagnosing, treating and managing the disease. We combine patented Intracellular Analytics with the use of DNA Nanoprobes and AI to diagnose Alzheimer’s desease before the symptoms manifest.
A whole new way of discovering novel pathways for Brain health
Voltair
DNA-based sensor for absolute membrane potential of cell and organelle membranes. Relevant to various neurological diseases, hypokalemia, or hyperkalemia
CalipHluor
DNA-based, ratiometric combination reporter of pH and Ca2+. Relevant to Alzheimer’s disease, Pakinson's disease and Kufor Rakeb syndrome.
Clensor
pH-independent, ratiometric Cl- sensor, single colour, multiplexing enabled. Relevant to Lysosomal storage disorders and Niemann Pick.
NOckout
DNA-based ratiometric NO sensitive probes. Relevant to cancer, autoimmune disease, sepsis and trauma, and vascular disease.
Accelerate Drug Development
Our ratio-metric assays and multiplexed proteomic panels are exceptional in their ability to quantify the key chemicals within endosomes (early, recycling, and late), lysosomes, and the golgi. They can be used to complement drug discovery and patient stratification, as well as assess drug efficacy as an end point in clinical trials for lysosomal storage disorders and numerous neurocognitive impairments.
Esya's vision is to set a new global standard in brain health by integrating biomarker analysis and deep learning to drive transformative drug discovery, delivering insights that refine precision medicine
A 360° Perspective For Alzheimer's Disease
We are a start-up originally spun out of Dr. Yamuna Krishnan’s lab at the University of Chicago, now based across London, UK and the U.S.
Get in touch to discuss how our probes can help you with your work .
If You Crave Challenges, There’s No Better Place To Be
Esya is a dynamic company operating at the intersection of biochemistry, technology, and medicine. If you crave challenges and the chance to see your work impact the millions of lives touched by Alzheimer’s disease, there’s no better place to be.
